S1 BIOPHARMA

s1-biopharma-logo

S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of sexual dysfunction in both women and men. The companyโ€™s development programs include first-in-class non-hormonal therapies designed to treat diminished sexual desire by restoring the natural balance of key neurotransmitters in the brain. The companyโ€™s lead product candidate, Lorexys, is currently positioned to advance to a Phase 2b clinical trial for the treatment of hypoactive sexual desire disorder (HSDD) in women. S1 Biopharma is evaluating partnerships, collaborations and out-licensing deals that will enable the company to rapidly advance its sexual dysfunction franchise as well as to accelerate the path to commercialization for its drug candidates in the U.S. and internationally.

#SimilarOrganizations #Website #More

S1 BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Life Science Pharmaceutical

Founded:
2010-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.s1biopharma.com

Total Employee:
1+

Status:
Active

Contact:
201-839-0941

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Euro WordPress 6.0 Gravatar Profiles


Similar Organizations

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

shifa-biomedical-logo

Shifa Biomedical

Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.

stromatis-pharma-logo

Stromatis Pharma

Stromatis Pharma is developing a secreted frizzle-related protein 2 (sFRP2) antagonist for reverting stromal stellate cells.

Stock Details


Company's stock symbol is NASDAQ:SXB

Official Site Inspections

http://www.s1biopharma.com

  • Host name: 108.181.20.77
  • IP address: 108.181.20.77
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "S1 Biopharma"

S1 Biopharma

Visit the post for more. March 4, 2021 S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage Innovations in Womenโ€™s Health; December 1, 2019 Dose-Finding Study of Lorexys for Hypoactive โ€ฆSee details»

S1 Biopharma - Crunchbase Company Profile & Funding

S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of sexual dysfunction in both women and men. The companyโ€™s development programs include โ€ฆSee details»

MANAGEMENT - S1 Biopharma

See details»

S1 Biopharma Company Profile 2024: Valuation, โ€ฆ

Www.s1biopharma.com. Formerly Known As. S1 Pharmaceuticals. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 7 World Trade Center; 250 Greenwich Street, 46th Floor; โ€ฆSee details»

S1 Biopharma - Org Chart, Teams, Culture & Jobs - The Org

View S1 Biopharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

S1 Biopharma Company Profile | Management and Employees List

Www.s1biopharma.com S1 Biopharma Profile and History S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company developing treatments for sexual dysfunction in both women and โ€ฆSee details»

S1 Biopharma Inc - Company Profile and News - Bloomberg Markets

Company profile page for S1 Biopharma Inc including stock price, company news, executives, board members, and contact informationSee details»

S1 Biopharma, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for S1 Biopharma, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

S1 Biopharma - LinkedIn

Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men. The โ€ฆSee details»

BOARD OF DIRECTORS - S1 Biopharma

Prior to joining NuPathe Inc., Ms. Hollingsworth served as Executive Vice President and was a co-founder of Auxilium Pharmaceuticals Inc., a publicly traded biopharmaceutical company, and โ€ฆSee details»

S1 Biopharma - VentureRadar

Website: http://s1biopharma.com/ S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men.See details»

S1 Biopharma - Overview, News & Similar companies - ZoomInfo

Mar 1, 2021 S1 Biopharma contact info: Phone number: (201) 839-0941 Website: www.s1biopharma.com What does S1 Biopharma do? S1 Biopharma, Inc. is a clinical-stage โ€ฆSee details»

S1 Biopharma - Craft

S1 Biopharma is a company developing drugs for the treatment of sexual dysfunction in both women and men. Its non-hormonal therapies act on the sexual centers of the brain by โ€ฆSee details»

S1 Biopharma - Contacts, Employees, Board Members

S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men.See details»

CONTACT US - S1 Biopharma

S1 Biopharma, Inc. 7 World Trade Center 250 Greenwich St. 46th Floor New York City, NY 10007 Email: [email protected]See details»

Working at S1 Biopharma - Glassdoor

Glassdoor gives you an inside look at what it's like to work at S1 Biopharma, including salaries, reviews, office photos, and more. This is the S1 Biopharma company profile.See details»

S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group โ€ฆ

NEW YORK, March 2, 2021 /PRNewswire/ -- S1 Biopharma, Inc. (S1), a clinical stage company advancing therapies based on central nervous system targets mediating sexual response, โ€ฆSee details»

NEWSROOM - S1 Biopharma

Feb 19, 2016 Visit the post for more. March 4, 2021 S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage Innovations in Womenโ€™s Health; โ€ฆSee details»

PRESS RELEASES - S1 Biopharma

March 4, 2021 S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage Innovations in Womenโ€™s Health; December 1, 2019 Dose-Finding Study of Lorexys โ€ฆSee details»

linkstock.net © 2022. All rights reserved